Medigen Biotechnology Corp. announced the appointment of Mr. Chieh-Liang Lin, Senior Associate Vice President of Cell Therapy Department of the company, as Chief Scientific Officer. Approved by the Board of Directors on March 11, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.7 TWD | -0.13% | +1.66% | -11.38% |
1st Jan change | Capi. | |
---|---|---|
-11.38% | 172M | |
+30.99% | 50.85B | |
+1.46% | 42.82B | |
+48.77% | 42.03B | |
-4.22% | 29.55B | |
+11.03% | 26.11B | |
-22.28% | 19.13B | |
+7.54% | 13.05B | |
+26.80% | 12.16B | |
+23.30% | 12.08B |
- Stock Market
- Equities
- 3176 Stock
- News Medigen Biotechnology Corp.
- Medigen Biotechnology Corp. Announces Appointment of Chieh-Liang Lin as Chief Scientific Officer